Business
Eurobio Scientific: 2025 FY revenue
FISCAL YEAR 2025, CONFIRMATION OF STRATEGIC TRANSFORMATION 9% increase in annual revenue to €168 millionDeployment of the Group's strategy: Proprietary products: 35% of revenueInternationalization: 42% of revenue generated outside France Strengthening of activities in Italy with the acquisition of Quimark and the assets of the Life Sciences unit of Voden Medical Instruments Spa Paris, January 27, 2026 - 5:40 p.m. - Eurobio Scientific (FR0013240934, ALERS), a leading French group in in vitro medi
About this update from Eurobio-scientific Sa
[{"type":"image","alt":"Eurobio Scientific","displaySize":"","headline":null,"caption":"Eurobio Scientific","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":148,"url":"https://media.zenfs.com/en/globenewswire.com/02090ccab968679ed439b14c01a240ae"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2t99Bha0ZUXR_So.tT1d_g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIwNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/02090ccab968679ed439b14c01a240ae","width":300,"height":148}},"lazy":false},{"type":"text","content":"FISCAL YEAR 2025, ","length":17,"tagName":"p"},{"type":"text","content":"CONFIRMATION OF STRATEGIC TRANSFORMATION","length":40,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"9% increase in annual revenue to €168 million","length":45,"tagName":"p"}]},{"val":[{"type":"text","content":"Deployment of the Group's strategy:","length":39,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Proprietary products: 35% of revenue","length":36,"tagName":"p"}]},{"val":[{"type":"text","content":"Internationalization: 42% of revenue generated outside France","length":61,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":97,"olType":false}]},{"val":[{"type":"text","content":"Strengthening of activities in Italy with the acquisition of Quimark and the assets of the Life Sciences unit of Voden Medical Instruments Spa","length":142,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":323,"olType":false},{"type":"text","content":"Paris, January 27, 2026 - 5:40 p.m. - Eurobio Scientific (FR0013240934, ALERS), a leading French group in in vitro medical diagnostics and life sciences today presents its consolidated annual revenue as of December 31, 2025.","length":224,"tagName":"p"},{"type":"text","content":"9% growth in revenue","length":20,"tagName":"p"},{"type":"text","content":"Eurobio Scientific recorded revenue of €168 million at the end of December 2025, compared with €154.2 million at the end of December 2024, representing an increase of +9%. On a comparable pro forma basis, i.e., excluding the impact of acquisitions on the scope of consolidation, growth amounted to +2.3%.","length":304,"tagName":"p"},{"type":"text","content":"The scope effects for 2025 are detailed as follows:","length":51,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","conte...